Drug cos focus on automation work culture to meet compliance


Faced with increasing regulatory scrutiny — Indian drug makers working more closely then ever before on Friday said they have been investing on automation, simplifying and standardizing systems and working on building culture of compliance within their organizations — as they don’t want to be seen as outliers in terms of regulatory compliance.
Source: Top News